Electronic Clinical Trial Protocol Management System

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current clinical trial management systems lack flexibility in managing complex clinical trial protocols, requiring lengthy processes for customization and modification, especially when dealing with variable treatment cycles and iterations, which increases time and resource requirements and complicates regulatory validation.

Innovation Solution

An electronic clinical trial protocol management system that uses programmatic elements and formulaic representations to model and interact with clinical trial protocols, allowing for a flexible number of treatment cycle iterations and procedures, enabling dynamic scheduling and adaptation without extensive reencoding or revalidation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If current clinical trial management systems are used to manage complex clinical trial protocols with variable treatment cycles, then the systems require lengthy processes for customization and modification, but this increases time and resource requirements and complicates regulatory validation

Engineering Contradiction:
Improveflexibility in managing clinical trial protocolsVSAvoidtime for customization and modification
Core Design Contradiction:
Adaptability or versatilityVSLoss of time

Solution Approach 1:

The system employs dynamic treatment cycle programmatic elements that can adapt to variable iterations without requiring static reconfiguration. The occurrence programmatic elements dynamically determine which procedures apply based on the subject's current position in the trial, allowing the system to flexibly accommodate different treatment cycle structures without lengthy customization processes.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system changes parameters by using programmatic elements with formulaic representations that can be modified through parameter adjustment rather than structural reconfiguration. This allows clinical trial protocols to be customized by changing parameters within the existing framework, significantly reducing the time and resources needed for adaptation while maintaining regulatory compliance.

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If current clinical trial management systems are used to manage complex clinical trial protocols, then the systems require extensive reencoding and revalidation, but this increases resource requirements

Engineering Contradiction:
Improveflexibility in modeling treatment cyclesVSAvoidresource requirements
Core Design Contradiction:
Adaptability or versatilityVSQuantity of substance

Solution Approach 1:

The programmatic elements serve multiple functions: they define treatment cycles, determine procedure applicability, track subject progression, and generate scheduling information. This multi-functionality eliminates the need for separate encoding structures for different trial components, reducing overall resource requirements while maintaining high adaptability for modeling various treatment cycle configurations.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system performs preliminary action by pre-defining programmatic elements and formulaic representations that can be reused across different trial scenarios. This preliminary structuring allows for rapid adaptation to new protocols without extensive reencoding, as the foundational elements are already in place and can be configured through parameter adjustment rather than creating new structures from scratch.

Inventive Principle:
Principle #10Preliminary action

3Adaptability or versatility

If current clinical trial management systems are used, then managing variable treatment cycle iterations is complex, but this complicates regulatory validation

Engineering Contradiction:
Improveability to handle variable treatment cyclesVSAvoidsystem complexity for regulatory validation
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The system uses dynamic programmatic elements that automatically adapt to variable treatment cycle iterations through formulaic representations. This dynamic approach simplifies regulatory validation because the system's behavior is determined by configurable parameters and formulas rather than complex hard-coded logic, making it easier to demonstrate compliance and validate against regulatory requirements.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system uses formulaic representations that can be copied and reused across different treatment cycles and iterations. This copying mechanism reduces system complexity for validation purposes, as the same validated formulaic structures can be applied repeatedly with different parameters, rather than requiring separate validation for each unique configuration.

Inventive Principle:
Principle #26Copying

Data Source

PatentUS20230410959A1Electronic clinical trial protocol management systems and related methods
Publication Date: 2023.12.21 FLATIRON HEALTH INC
  • US20230410959A1 patent drawing
  • US20230410959A1 patent drawing
  • US20230410959A1 patent drawing

AI summary

Methods and systems for interacting with and/or managing a clinical trial protocol via an electronic clinical trial protocol management system. The electronic clinical trial protocol management system capable of handling one or more treatment cycles within the clinical trial protocol, and having one or more occurrence programmatic elements and one or more treatment cycle programmatic elements. Each occurrence programmatic element includes a formulaic representation of scheduling of a clinical procedure within one or more treatment cycles. Procedure programmatic elements are related to one or more iterations of a treatment cycle programmatic element. Via such a relationship it is possible to determine a proper clinical procedure applicable to a subject at a position in a clinical trial using an occurrence programmatic element.